← All trials
NCT02694393
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2016
- Primary completion
- Jan 1, 2017
- Completion date
- Jan 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 35
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of PittsburghLead sponsor
- University of PittsburghOverall official - principal investigator
- University of PittsburghReponsible party - principal investigator
- Cystic Fibrosis Foundation TherapeuticsCollaborator
- Mast TherapeuticsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.